Clinical Trial Update: CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating CAR20(NAP)-T therapy for B-cell lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma

Drugs mentioned

• CAR20(NAP)-T Therapy (CAR20(NAP)-T)

Snippet

Sponsor: Uppsala University | Conditions: B-cell Lymphoma | Phase 1, Phase 2 | Status: RECRUITING